Leigh Dallow has been hired as the Director of Business Development for the Eastern United States. The news was announced today by BioSurplus.
Bill VanDeWeghe, president and CEO of BioSurplus comments: “We are thrilled to have someone with Leigh’s industry knowledge and experience join our team. Having worked in sales and business development for major corporations, she brings valuable insight regarding the needs of our customers and the market. She is a huge asset and will be instrumental to our growth in Boston and the East Coast.”
Leigh Dallow added, “I am thrilled to be working with an industry leader, providing solutions for labs across the country, from the largest biopharma companies that need to monetize excess assets, to early stage companies that need inexpensive tools for their research. BioSurplus ensures that the needs of scientists are met in a cost-effective manner that keeps equipment out of landfills.”
Leigh Dallow has worked in the life science and healthcare sectors for more than 15 years, starting in sales for Pfizer, Eli Lilly, and Forest Pharmaceuticals before serving as the vice president of sales and business development for SironaHealth, Inc. She has also served as senior vice president of corporate development at International Healthcare Regulatory Advisors, where she assisted medical practices in developing unique business models that allowed for maximized growth within the standards of regulatory compliance. Leigh holds a Bachelor of Arts degree in psychology from Ithaca College.